Effective Dosing of Burosumab in XLH

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
X-linked Hypophosphatemia (XLH)
Trial Locations (1)

NG7 2UH

RECRUITING

Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
collaborator

Nottingham University Hospitals NHS Trust

OTHER

collaborator

Birmingham Women's and Children's NHS Foundation Trust

OTHER

collaborator

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

Sheffield Children's NHS Foundation Trust

OTHER

collaborator

Manchester University NHS Foundation Trust

OTHER_GOV

collaborator

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

collaborator

Alder Hey Children's NHS Foundation Trust

OTHER

lead

University of Nottingham

OTHER

NCT07183579 - Effective Dosing of Burosumab in XLH | Biotech Hunter | Biotech Hunter